IP Library Granted Patent US 9,950,008
Granted Patent B1
US 9,950,008 · App. 14/829,728 · Granted Apr 24, 2018

Chewable eye health formulation

Inventors: Marc Bellemore (Windsor, CA); Megan Thomas (Windsor, CA); Ashley V Kasurak (Windsor, CA); Paul Charlton (Windsor, CA); John Doherty (Windsor, CA); Sorin Popa (Windsor, CA)
A61K33/30A61K9/0056A61K31/047A61K31/355A61K31/375A61K33/34A61K36/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,950,008
App. No.
14/829,728
Granted
Apr 24, 2018
Kind
B1
Abstract

Risk of visual impairment including Age-Related Macular Degeneration (AMD) and cataracts increase with age. This increased risk can be caused by changes in the structure and function of the eye or changes in structures of the central nervous system that support visual perception. The present invention comprises fruit flavored, chewable formulations of supplements for reducing the risk of AMD. Chewable dosage forms of the invention are preferred over other formulations and may increase compliance in an aging population, who are more likely to require an eye health supplement and have an increased risk of experiencing dysphagia.

Claims (6)

1. A chewable composition comprising bilberry fruit extract, natural fruit flavor, 250 mg Vitamin C, 134 mg AT/200 IU Vitamin E, 12.5 mg Zinc as zinc oxide, 0.5 [to 1.0] mg copper as copper citrate, 5 mg lutein from marigold flower and 1 mg zeaxanthin from marigold flower.

2. A composition according to claim 1 wherein the fruit flavor is strawberry, raspberry, or blueberry.

3. A method of reducing the risk of advanced age-related macular degeneration by providing a person at risk with a daily supplement comprising the chewable composition according to claim 1 .

4. A method of reducing the risk of advanced age-related macular degeneration by providing a person at risk with a daily supplement comprising the chewable composition according to claim 2 .

5. A method of reducing the risk of dysphagia from an AREDS supplement by providing a person at risk with a daily supplement comprising the chewable composition according to claim 1 .

6. A method of reducing the risk of dysphagia from an AREDS supplement by providing a person at risk with a daily supplement comprising the chewable composition according to claim 2 .

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2019
From: JAMIESON WELLNESS,INC.
To: JAMIESON LABORATORIES, LTD
Reel/Frame 051316/0668 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2019
From: KASURAK, ASHLEY; POPA, SORIN
To: JAMIESON WELLNESS,INC.
Reel/Frame 050633/0922 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2019
From: BELLEMORE, MARC; DOHERTY, JOHN; THOMAS, MEGAN; CHARLTON, PAUL
To: JAMIESON WELLNESS,INC.
Reel/Frame 050633/0932 →
SECURITY INTEREST Recorded May 16, 2017
From: JAMIESON LABORATORIES LTD.
To: BANK OF MONTREAL
Reel/Frame 042397/0236 →
Continuity (1)
Provisional Application 62039852 · Aug 20, 2014